The ECCMID is indeed a very important and large conference. A great debut for the successful Brilacidin P2b Clinical Trial. (1 day Brilacidin vs 7 days Daptomycin)
Holy cow. That is one packed conference. Look at how many sessions there are! Unreal. TheHound
The value is not only the presentations themselves, but the follow up as Cellceutix makes use of the abstracts and presentations. Similar to ASCO for cancer. The impact a company makes goes well beyond just those who attend a session.
It should be noted that we don't "win" as such at ECCMID. Rather it is a forum to bring increased industry awareness of the win in progress.
Cellceutix wins by successful clinical trials and increased pre-clinical research that leads to clinical trials.